• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC CHLORAPREP ONE-STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC CHLORAPREP ONE-STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930480NSB
Device Problem Defective Component (2292)
Patient Problem Laceration(s) (1946)
Event Date 11/25/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4) initial mdr.A follow up will be submitted if additional information becomes available.(b)(4).
 
Event Description
It was reported that upon scrubbing the site, the foam pad came off and the glass shards exited the device onto the patients skin causing abraded cuts.
 
Manufacturer Narrative
Samples and a photo were received by our quality team for evaluation.Upon inspection of the sample, it was observed that the foam on the applicator was welded upside down; therefore, the incident could be verified.A review of the internal manufacturing device records and raw material history files for the reported lot numbers was performed and no recorded quality problems or rejections to this incident were found.Based on the investigation, the most probable root cause of the foam coming off the applicator during use was the incorrect orientation of the foam tip at the time of manufacturing.The foam welding onto the applicators consists of two parts.One part is foam and the other part is a thin novonette that is glued to the foam.The function of the novonette is to facilitate the welding of the foam to the plastic applicator.When assembled the 1ml applicators must have the foam positioned in such a way that the novonette of the foam is in contact with the plastic applicator.The sample shows that the unit was assembled with the foam upside down.Without the presence of the novonette between the foam and the plastic applicator the welding process was unsuccessful resulting on an open weld.To prevent this incident from happening, all 1ml assembly machines have two vision systems that ensure the proper orientation of the foam.If the foam is placed incorrectly the part is not welded and is removed from the assembly process.All sensors were checked on all three 1ml assembly machines and they were performing appropriately.Sensors are checked at the beginning of every shift as part of the setup process.An additional check during the creation of each lot has now been added to the manufacturing process.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see narrative below.
 
Event Description
It was reported that upon scrubbing the site, the foam pad came off and the glass shards exited the device onto the patients skin causing abraded cuts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE-STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
MDR Report Key11005130
MDR Text Key221467222
Report Number3004932373-2020-00151
Device Sequence Number1
Product Code KXF
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 02/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date01/31/2023
Device Catalogue Number930480NSB
Device Lot Number0219708
Initial Date Manufacturer Received 11/30/2020
Initial Date FDA Received12/14/2020
Supplement Dates Manufacturer Received02/04/2021
Supplement Dates FDA Received02/04/2021
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age59 YR
-
-